J D Wetherspoon plc (FRA:0QW)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is August - July.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Jul 28, 2024	Jul 30, 2023	Jul 31, 2022	Jul 25, 2021	Jul 26, 2020
Market Capitalization	924	1,068	1,025	842	1,556	1,159
Market Cap Growth	-26.18%	4.18%	21.66%	-45.86%	34.31%	-34.25%
Enterprise Value	2,205	2,399	2,437	2,541	3,262	2,762
Last Close Price	8.30	8.40	7.63	6.35	13.28	9.53
PE Ratio	12.48	18.49	14.75	36.66	-	-
PS Ratio	0.38	0.44	0.46	0.41	1.72	0.84
PB Ratio	1.98	2.25	2.13	2.19	4.79	3.32
P/TBV Ratio	2.02	2.28	2.16	2.23	4.88	3.42
P/FCF Ratio	9.76	13.27	2.89	14.81	-	-
P/OCF Ratio	4.06	5.23	2.42	5.92	-	62.87
EV/Sales Ratio	0.93	1.00	1.09	1.22	3.61	1.99
EV/EBITDA Ratio	8.66	9.82	11.78	21.95	-	-
EV/EBIT Ratio	14.39	14.21	19.52	82.81	-	-
EV/FCF Ratio	23.28	29.80	6.87	44.67	-	-
Debt / Equity Ratio	3.04	2.84	2.85	4.37	5.23	5.19
Debt / EBITDA Ratio	5.37	4.70	5.47	10.10	-	165.52
Debt / FCF Ratio	14.94	16.80	3.86	29.52	-	-
Asset Turnover	1.08	1.05	0.96	0.86	0.36	0.67
Inventory Turnover	60.51	57.10	56.13	60.09	38.55	53.40
Quick Ratio	0.31	0.21	0.26	0.19	0.15	0.56
Current Ratio	0.40	0.35	0.41	0.30	0.27	0.73
Return on Equity (ROE)	16.38%	11.98%	16.21%	6.42%	-59.48%	-30.77%
Return on Assets (ROA)	4.36%	4.59%	3.32%	0.79%	-9.08%	-3.80%
Return on Capital (ROIC)	5.34%	5.69%	4.03%	0.93%	-10.47%	-4.61%
Return on Capital Employed (ROCE)	8.40%	9.20%	6.70%	1.50%	-	-
Earnings Yield	8.02%	5.41%	6.78%	2.73%	-13.30%	-9.26%
FCF Yield	10.25%	7.54%	34.62%	6.75%	-5.60%	-11.96%
Dividend Yield	2.27%	1.69%	-	-	-	-
Payout Ratio	23.74%	-	-	-	-	-
Buyback Yield / Dilution	4.38%	2.52%	0.33%	-4.78%	-15.27%	-1.06%
Total Shareholder Return	6.65%	4.21%	0.33%	-4.78%	-15.27%	-1.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.